Biofrontera (BFRI) Earnings Analysis

Biofrontera (BFRI) next reports earnings on 2026-08-12, consensus EPS -0.105 USD. Last quarter (2026-05-14) it missed with EPS -0.41 USD vs -0.115 USD est (-256.5%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -0.96.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BFRI next report earnings?

Next earnings date2026-08-12
Consensus EPS estimate-0.105 USD
Revenue estimate0.01B

BFRI earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-14-0.41 USD-0.115 USD-256.5%Miss
2026-03-190.5 USD0.29 USD+72.4%Beat
2025-11-12-0.59 USD-0.6 USD+1.7%Beat
2025-08-13-0.57 USD-0.45 USD-26.7%Miss
2025-05-15-0.47 USD-0.14 USD-235.7%Miss
2025-03-21-2.33 USD0.02 USD-11750%Miss
2024-08-14-1.12 USD-1.19 USD+5.9%Beat

Beat rate: 3/7 (43%) over reported quarters with consensus data.

BFRI valuation and analyst view

Trailing P/E-0.96
Trailing EPS-0.94879 USD
Price / book2.08
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (1 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Biofrontera (BFRI)'s next earnings date?

Biofrontera is next scheduled to report on 2026-08-12, with a consensus EPS estimate of -0.105 USD and revenue estimate of 0.01B.

Did BFRI beat earnings last quarter?

In its 2026-05-14 report, BFRI posted EPS of -0.41 USD versus a -0.115 USD estimate — a miss of 256.5%.

What is BFRI's earnings track record?

Over the last 7 reported quarters with consensus data, BFRI beat estimates 3 times (43%).

What is BFRI's current P/E ratio and EPS?

BFRI trades at a trailing P/E of -0.96 on trailing EPS of -0.9487882856615365 USD.

What do analysts rate BFRI?

Analyst consensus is "Buy" across 1 ratings (0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell).